Industrial Purity Specifications and Technical Analysis for 2-Chloro-3-Fluoro-4-Iodopyridine
- High-Purity Standards: Industrial grades typically exceed 98.0% purity verified by GC/HPLC.
- Process Control: Optimized lithiation and iodination routes minimize di-halogenated impurities.
- Bulk Supply: Scalable manufacturing ensures consistent quality for pharmaceutical intermediates.
In the realm of advanced pharmaceutical synthesis, the reliability of halogenated pyridine building blocks is paramount. 2-Chloro-3-fluoro-4-iodopyridine (CAS: 148639-07-0) serves as a critical intermediate for constructing complex heterocyclic architectures found in kinase inhibitors and agrochemical agents. For process chemists and procurement specialists, understanding the nuance between laboratory-grade reagents and industrial-grade specifications is essential for successful scale-up. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to rigorous quality control protocols to ensure that every batch meets the demanding requirements of modern drug discovery.
Understanding ≥98.0% Purity Standards in Pharma Intermediates
When evaluating technical data sheets for polyhalogenated pyridines, the stated purity percentage often masks the specific profile of impurities. For 2-Chloro-3-fluoro-4-iodopyridine, achieving an industrial purity of 98% or higher requires precise control over the halogenation sequence. Standard analytical methods such as Gas Chromatography (GC) and High-Performance Liquid Chromatography (HPLC) are utilized to quantify the main peak area against known impurities.
Key impurities often arise from incomplete reaction conversion or over-halogenation. Common contaminants include:
- Proto-dehalogenated species: Resulting from premature quenching during lithiation.
- Di-iodinated byproducts: Caused by excessive iodine equivalents or poor temperature control.
- Isomeric impurities: Such as 2-chloro-5-fluoro-4-iodopyridine, depending on the starting material quality.
Industrial specifications must also account for residual solvents (e.g., THF, ethylbenzene) and heavy metals, particularly if palladium catalysts are employed in downstream coupling. A comprehensive COA (Certificate of Analysis) should detail these parameters, ensuring compliance with ICH Q3 guidelines for residual solvents.
Impact of Impurities on Downstream Cross-Coupling Reactions
The utility of this compound lies primarily in its ability to undergo selective metal-catalyzed cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig aminations. The presence of impurities can significantly detrimentally affect reaction synthesis route efficiency. For instance, residual iodine or oxidized species can poison palladium catalysts, leading to reduced turnover numbers and lower isolated yields.
Furthermore, the physical form of the material impacts handling. While laboratory samples may appear as white to light yellow crystals, industrial batches must maintain consistent particle size distribution to ensure uniform dissolution in reactor vessels. Storage conditions are equally critical; the compound should be kept in a dark, sealed environment at room temperature to prevent photodegradation or oxidation of the iodine moiety. Deviations in storage can lead to discoloration (turning light orange) and a drop in assay value, compromising the manufacturing process integrity.
Technical Specifications and Physical Properties
Below is a summary of the critical physical and chemical properties expected from a high-quality industrial supplier. These metrics serve as a benchmark for quality assurance during incoming goods inspection.
| Property | Specification |
|---|---|
| CAS Number | 148639-07-0 |
| Molecular Formula | C5H2ClFIN |
| Molecular Weight | 257.43 g/mol |
| Purity (GC/HPLC) | ≥ 98.0% |
| Melting Point | 95 - 99 °C |
| Appearance | White to Light Yellow Crystalline Powder |
| Solubility | Soluble in Methanol, DCM, THF |
| Storage | Sealed, Dry, Dark, Room Temperature |
COA Requirements and Quality Assurance Protocols for Bulk Shipments
Procuring chemicals for large-scale production necessitates a robust quality assurance framework. Unlike small-scale research purchases where bulk price sensitivity is lower, industrial contracts demand consistency across multiple tons. A valid COA must include batch-specific data on assay, loss on drying, and residue on ignition. Additionally, traceability of raw materials used in the manufacturing process ensures that no prohibited substances enter the supply chain.
For procurement managers evaluating suppliers, it is vital to confirm the manufacturer's capacity to handle hazardous intermediates safely. When sourcing high-purity 2-Chloro-3-fluoro-4-iodopyridine, buyers should verify that the supplier employs validated analytical methods rather than relying solely on titration. NINGBO INNO PHARMCHEM CO.,LTD. provides full technical support and batch documentation to facilitate regulatory filings for downstream pharmaceutical products.
Conclusion: Securing Reliable Supply Chains
The strategic importance of fluorinated and iodinated building blocks continues to grow in medicinal chemistry. Ensuring a stable supply of 2-Chloro-3-fluoro-4-iodopyridine with consistent industrial purity is a key factor in maintaining production timelines. By prioritizing suppliers who offer transparent COA data and scalable manufacturing process capabilities, companies can mitigate the risks associated with complex synthetic routes. For partners seeking a reliable global manufacturer committed to quality and technical excellence, establishing a direct line with established chemical producers is the most effective strategy for long-term success.